论文部分内容阅读
Photodynamic therapy (PDT) is a promising modality for the treatment of cancer and many other diseases[1].5-Aminolevulinic acid (ALA),a FDA-approved PDT precursor of protoporphyrin Ⅸ (PplⅨ),is gaining increasing attention because of its nontoxicity and fast metabolization from biological systems.However,the internalization of ALA is a big challenge due to the hydrophilic nature and low specificity to cancer cells[2].